Versene es una solución de ácido etildiaminotetraacético (EDTA) para el uso como reactivo suave de disasociación de células no enzimáticas.Más información
Have Questions?
Número de catálogo
Cantidad
15040066
100 mL
Número de catálogo 15040066
Precio (CLP)
17.079
Each
Añadir al carro de la compra
Cantidad:
100 mL
Precio (CLP)
17.079
Each
Añadir al carro de la compra
Versene es una solución de ácido etildiaminotetraacético (EDTA) para el uso como reactivo suave de disasociación de células no enzimáticas. La solución Gibco™ Versene (0,48 mM) se formula en forma de 0,2 g EDTA (Na4) por litro de solución salina tamponada con fosfato (PBS).
Uso del producto Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Sistema de fabricación y calidad con prácticas recomendadas de fabricación actuales en dos instalaciones La solución Versene Gibco™ se fabrica en instalaciones que cumplen los principios de prácticas recomendadas actuales, ubicadas en Grand Island, Nueva York (EE. UU.). Las instalaciones se han registrado en la Agencia estadounidense de alimentos y medicamentos (FDA) como fabricante de dispositivos médicos y tienen la certificación según la norma ISO 13485. Para la continuidad de la cadena de suministro, ofrecemos un producto de solución Gibco™ Versene idéntico fabricado en nuestras instalaciones de Escocia (15040-033). Estas instalaciones también están registradas en la Agencia estadounidense de alimentos y medicamentos (FDA), calificadas como punto de fabricación de dispositivos médicos y están certificadas según la norma ISO 13485.
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
QuelantesEDTA
Calidad de fabricacióncGMP para dispositivos médicos, 21 CFR parte 820 e ISO 13485
Cantidad100 mL
Duración de almacenamiento18 meses
Condiciones de envíoTemperatura ambiente
ClasificaciónLibre de material de origen animal
Tipo de productoReactivo para disociación de cultivo celular
EsterilidadEstéril con filtro
Con aditivosEDTA
Unit SizeEach
Contenido y almacenamiento
Condiciones de almacenamiento: De 2 a 8 °C Condiciones de envío: Ambiente Vida útil: 18 meses a partir de la fecha de fabricación
Preguntas frecuentes
Can PSCs transitioned over into Essential 8 Medium on recombinant human laminin-521 (rhLaminin-521) from feeder-dependent cultures, then be transferred onto vitronectin (VTN-N)?
Yes. Following 2 passages on the rhLaminin-521 matrix, Versene or EDTA passaging should be used to subculture PSCs.
What are the main differences to be taken into consideration when culturing cells in Gibco Essential 8 Medium on Gibco Vitronectin (VTN-N) compared to other feeder-free systems?
Here are three major differences to be taken into consideration when culturing cells
in Gibco Essential 8 Medium on Gibco Vitronectin (VTN-N) compared to other feeder-free
systems:
- Cells should be typically passaged ~24 hours sooner than they would be with other feeder-free
media.
- Passaging should take place when cells are at ~85% confluency. If cells are passaged when they
are more than 85% confluent, the health of the cells and final cell yield may be compromised.
- Cells must be passaged in EDTA. Collagenase and dispase are not recommended.
Can pluripotent stem cells (PSCs) previously cultured in other media and on other substrates be cultured in Gibco Essential 8 Medium and on Gibco Vitronectin?
Cells cultured in other feeder-free media systems, such as mTeSR Medium with Matrigel Basement Membrane Matrix, or StemPro hESC SFM with Geltrex Matrix, can be
successfully cultured in Gibco Essential 8 Medium and VTN-N. In addition, PSCs grown on feeders with KnockOut SR have also been shown to be successfully cultured in Gibco Essential 8 Medium on VTN-N. However, when changing media systems, cells must be passaged either manually, or
with EDTA prior to culturing in Gibco Essential 8 Medium on VTN-N.
What is the recommended passaging method to use with Gibco Essential 8
Medium and on Gibco Vitronectin (VTN-N)?
Cells cultured in Gibco Essential 8 Medium and VTN-N need to be passaged with EDTA.
I currently use mTeSR1. How difficult would it be to adapt my cells to the StemFlex Medium system?
This transition is very straightforward. We recommend at least a 2-passage transition into the StemFlex Medium system. Briefly, if you have cryopreserved cells previously cultured in the mTeSR1/Matrigel system, we recommend thawing the cells back into mTeSR1/Matrigel until fully recovered. Upon reaching ~70-85% confluency, passage using Versene solution and seed directly into the StemFlex Medium system.
Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis.
Authors: Hayward Lawrence J; Rodriguez Jorge A; Kim Ji W; Tiwari Ashutosh; Goto Joy J; Cabelli Diane E; Valentine Joan Selverstone; Brown Robert H Jr;
Journal:J Biol Chem
PubMed ID:11854284
Over 90 different mutations in the gene encoding copper/zinc superoxide dismutase (SOD1) cause approximately 2% of amyotrophic lateral sclerosis (ALS) cases by an unknown mechanism. We engineered 14 different human ALS-related SOD1 mutants and obtained high yields of biologically metallated proteins from an Sf21 insect cell expression system. Both the ... More
Molecular determinants of receptor binding and signaling by the CX3C chemokine fractalkine.
Authors: Mizoue L S; Sullivan S K; King D S; Kledal T N; Schwartz T W; Bacon K B; Handel T M;
Journal:J Biol Chem
PubMed ID:11432858
Fractalkine/CX3CL1 is a membrane-tethered chemokine that functions as a chemoattractant and adhesion protein by interacting with the receptor CX3CR1. To understand the molecular basis for the interaction, an extensive mutagenesis study of fractalkine's chemokine domain was undertaken. The results reveal a cluster of basic residues (Lys-8, Lys-15, Lys-37, Arg-45, and ... More